Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo.

Altinoz MA, Nalbantoglu J, Ozpinar A, Emin Ozcan M, Del Maestro RF, Elmaci I.

Clin Neurol Neurosurg. 2018 Oct;173:20-30. doi: 10.1016/j.clineuro.2018.07.012. Epub 2018 Jul 19.

PMID:
30055402
2.

Ring cell migration assay identifies distinct effects of extracellular matrix proteins on cancer cell migration.

Chen H, Nalbantoglu J.

BMC Res Notes. 2014 Mar 27;7:183. doi: 10.1186/1756-0500-7-183.

3.

The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP).

Houri N, Huang KC, Nalbantoglu J.

PLoS One. 2013 Aug 28;8(8):e73296. doi: 10.1371/journal.pone.0073296. eCollection 2013.

4.

Strength and muscle specificity of a compact promoter derived from the slow troponin I gene in the context of episomal (gutless adenovirus) and integrating (lentiviral) vectors.

Robert MA, Lin Y, Bendjelloul M, Zeng Y, Dessolin S, Broussau S, Larochelle N, Nalbantoglu J, Massie B, Gilbert R.

J Gene Med. 2012 Dec;14(12):746-60. doi: 10.1002/jgm.2675.

PMID:
23071006
5.

Inhibition of the protein tyrosine phosphatase SHP-1 increases glucose uptake in skeletal muscle cells by augmenting insulin receptor signaling and GLUT4 expression.

Bergeron S, Dubois MJ, Bellmann K, Schwab M, Larochelle N, Nalbantoglu J, Marette A.

Endocrinology. 2011 Dec;152(12):4581-8. doi: 10.1210/en.2011-1268. Epub 2011 Sep 27.

PMID:
21952243
6.

CT-GalNAc transferase overexpression in adult mice is associated with extrasynaptic utrophin in skeletal muscle fibres.

Durko M, Allen C, Nalbantoglu J, Karpati G.

J Muscle Res Cell Motil. 2010 Sep;31(3):181-93. doi: 10.1007/s10974-010-9222-9. Epub 2010 Aug 13.

PMID:
20706865
7.

TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation.

Newell MK, Tobin RP, Cabrera JH, Sorensen MB, Huckstep A, Villalobos-Menuey EM, Burnett M, McCrea E, Harvey CP, Buddiga A, Bar-Or A, Freedman MS, Nalbantoglu J, Arbour N, Zamvil SS, Antel JP.

J Leukoc Biol. 2010 Oct;88(4):779-89. doi: 10.1189/jlb.0410237. Epub 2010 Jul 14. Erratum in: J Leukoc Biol. 2010 Dec;88(6):1279. J Leukoc Biol. 2010 Dec;88(6):1279.

8.

A novel, rapidly acquired and persistent spatial memory task that induces immediate early gene expression.

Feldman LA, Shapiro ML, Nalbantoglu J.

Behav Brain Funct. 2010 Jul 2;6:35. doi: 10.1186/1744-9081-6-35.

9.

The cellular and developmental biology of medulloblastoma: current perspectives on experimental therapeutics.

Srivastava VK, Nalbantoglu J.

Cancer Biol Ther. 2010 Jun 1;9(11):843-52. Epub 2010 Jun 16. Review.

PMID:
20372085
10.

Modulation of coxsackie and adenovirus receptor expression for gene transfer to normal and dystrophic skeletal muscle.

Larochelle N, Teng Q, Gilbert R, Deol JR, Karpati G, Holland PC, Nalbantoglu J.

J Gene Med. 2010 Mar;12(3):266-75. doi: 10.1002/jgm.1433.

PMID:
20082422
11.

Impaired medulloblastoma cell survival following activation of the FOXO1 transcription factor.

Srivastava VK, Yasruel Z, Nalbantoglu J.

Int J Oncol. 2009 Nov;35(5):1045-51.

PMID:
19787258
12.

Differential response of glioma cells to FOXO1-directed therapy.

Lau CJ, Koty Z, Nalbantoglu J.

Cancer Res. 2009 Jul 1;69(13):5433-40. doi: 10.1158/0008-5472.CAN-08-4540. Epub 2009 Jun 23.

13.

Targeting artificial transcription factors to the utrophin A promoter: effects on dystrophic pathology and muscle function.

Lu Y, Tian C, Danialou G, Gilbert R, Petrof BJ, Karpati G, Nalbantoglu J.

J Biol Chem. 2008 Dec 12;283(50):34720-7. doi: 10.1074/jbc.M804518200. Epub 2008 Oct 21.

14.

Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.

Srivastava VK, Nalbantoglu J.

Cytometry A. 2008 Oct;73(10):940-8. doi: 10.1002/cyto.a.20633.

15.

Downregulation of CD46 during muscle differentiation: implications for gene transfer to human skeletal muscle using group B adenoviruses.

Larochelle N, Deol JR, Srivastava V, Allen C, Mizuguchi H, Karpati G, Holland PC, Nalbantoglu J.

Hum Gene Ther. 2008 Feb;19(2):133-42.

PMID:
18067405
16.

Successful compensation for dystrophin deficiency by a helper-dependent adenovirus expressing full-length utrophin.

Deol JR, Danialou G, Larochelle N, Bourget M, Moon JS, Liu AB, Gilbert R, Petrof BJ, Nalbantoglu J, Karpati G.

Mol Ther. 2007 Oct;15(10):1767-74. Epub 2007 Jul 31.

17.

IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo.

Drogat B, Auguste P, Nguyen DT, Bouchecareilh M, Pineau R, Nalbantoglu J, Kaufman RJ, Chevet E, Bikfalvi A, Moenner M.

Cancer Res. 2007 Jul 15;67(14):6700-7.

18.

Interaction of the Coxsackie and adenovirus receptor (CAR) with the cytoskeleton: binding to actin.

Huang KC, Yasruel Z, Guérin C, Holland PC, Nalbantoglu J.

FEBS Lett. 2007 Jun 12;581(14):2702-8. Epub 2007 May 21.

19.

Faithful companions: a proposal for neurooncology trials in pet dogs.

Kimmelman J, Nalbantoglu J.

Cancer Res. 2007 May 15;67(10):4541-4.

20.

Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.

Durocher Y, Pham PL, St-Laurent G, Jacob D, Cass B, Chahal P, Lau CJ, Nalbantoglu J, Kamen A.

J Virol Methods. 2007 Sep;144(1-2):32-40. Epub 2007 Apr 30.

PMID:
17467815
21.

Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.

Bourbeau D, Lau CJ, Jaime J, Koty Z, Zehntner SP, Lavoie G, Mes-Masson AM, Nalbantoglu J, Massie B.

Cancer Res. 2007 Apr 1;67(7):3387-95.

22.

The Coxsackie and adenovirus receptor binds microtubules and plays a role in cell migration.

Fok PT, Huang KC, Holland PC, Nalbantoglu J.

J Biol Chem. 2007 Mar 9;282(10):7512-21. Epub 2007 Jan 7.

23.

Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice.

Shaw CA, Larochelle N, Dudley RW, Lochmuller H, Danialou G, Petrof BJ, Karpati G, Holland PC, Nalbantoglu J.

Am J Pathol. 2006 Dec;169(6):2148-60.

24.

Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis.

Batulan Z, Taylor DM, Aarons RJ, Minotti S, Doroudchi MM, Nalbantoglu J, Durham HD.

Neurobiol Dis. 2006 Nov;24(2):213-25. Epub 2006 Sep 6.

PMID:
16950627
25.
26.

Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells.

Batulan Z, Nalbantoglu J, Durham HD.

Cell Stress Chaperones. 2005 Autumn;10(3):185-96.

27.

Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.

Perri SR, Nalbantoglu J, Annabi B, Koty Z, Lejeune L, François M, Di Falco MR, Béliveau R, Galipeau J.

Cancer Res. 2005 Sep 15;65(18):8359-65.

28.

Localization of coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle.

Sinnreich M, Shaw CA, Pari G, Nalbantoglu J, Holland PC, Karpati G.

Neuromuscul Disord. 2005 Aug;15(8):541-8.

PMID:
16014330
29.

Factors associated with induced chronic inflammation in mdx skeletal muscle cause posttranslational stabilization and augmentation of extrasynaptic sarcolemmal utrophin.

Waheed I, Gilbert R, Nalbantoglu J, Guibinga GH, Petrof BJ, Karpati G.

Hum Gene Ther. 2005 Apr;16(4):489-501.

PMID:
15871680
30.

Optimization of regional intraarterial naked DNA-mediated transgene delivery to skeletal muscles in a large animal model.

Danialou G, Comtois AS, Matecki S, Nalbantoglu J, Karpati G, Gilbert R, Geoffroy P, Gilligan S, Tanguay JF, Petrof BJ.

Mol Ther. 2005 Feb;11(2):257-66.

31.

Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs.

Shaw CA, Holland PC, Sinnreich M, Allen C, Sollerbrant K, Karpati G, Nalbantoglu J.

BMC Cell Biol. 2004 Nov 8;5(1):42.

32.
33.

Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury.

Wosik K, Ruffini F, Almazan G, Olivier A, Nalbantoglu J, Antel JP.

Brain. 2004 Dec;127(Pt 12):2636-48. Epub 2004 Oct 27.

PMID:
15509624
34.

Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: requirement for the C-terminal domain.

Huang KC, Altinoz M, Wosik K, Larochelle N, Koty Z, Zhu L, Holland PC, Nalbantoglu J.

Int J Cancer. 2005 Feb 20;113(5):738-45.

35.

Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles.

Molnar MJ, Gilbert R, Lu Y, Liu AB, Guo A, Larochelle N, Orlopp K, Lochmuller H, Petrof BJ, Nalbantoglu J, Karpati G.

Mol Ther. 2004 Sep;10(3):447-55.

36.

Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes.

Matecki S, Dudley RW, Divangahi M, Gilbert R, Nalbantoglu J, Karpati G, Petrof BJ.

Am J Physiol Lung Cell Mol Physiol. 2004 Sep;287(3):L569-76. Epub 2004 May 21.

37.

Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector.

Dudley RW, Lu Y, Gilbert R, Matecki S, Nalbantoglu J, Petrof BJ, Karpati G.

Hum Gene Ther. 2004 Feb;15(2):145-56.

PMID:
14975187
38.

The principles of molecular therapies for glioblastoma.

Karpati G, Nalbantoglu J.

Int Rev Neurobiol. 2003;55:151-63. Review. No abstract available.

PMID:
12968535
39.

High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1.

Batulan Z, Shinder GA, Minotti S, He BP, Doroudchi MM, Nalbantoglu J, Strong MJ, Durham HD.

J Neurosci. 2003 Jul 2;23(13):5789-98.

40.
41.

Oligodendrocyte injury in multiple sclerosis: a role for p53.

Wosik K, Antel J, Kuhlmann T, Brück W, Massie B, Nalbantoglu J.

J Neurochem. 2003 May;85(3):635-44.

42.

Ultrasound increases plasmid-mediated gene transfer to dystrophic muscles without collateral damage.

Danialou G, Comtois AS, Dudley RW, Nalbantoglu J, Gilbert R, Karpati G, Jones DH, Petrof BJ.

Mol Ther. 2002 Nov;6(5):687-93.

43.
44.

Strategies for muscle-specific targeting of adenoviral gene transfer vectors.

Thirion C, Larochelle N, Volpers C, Dunant P, Stucka R, Holland P, Nalbantoglu J, Kochanek S, Lochmüller H.

Neuromuscul Disord. 2002 Oct;12 Suppl 1:S30-9. Review.

PMID:
12206792
45.

The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice.

Larochelle N, Oualikene W, Dunant P, Massie B, Karpati G, Nalbantoglu J, Lochmuller H.

Biochem Biophys Res Commun. 2002 Apr 5;292(3):626-31.

PMID:
11922612
46.

Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice.

Guibinga GH, Ebihara S, Nalbantoglu J, Holland P, Karpati G, Petrof BJ.

Mol Ther. 2001 Nov;4(5):499-507.

47.

Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products.

Gilbert R, Nalbantoglu J, Howell JM, Davies L, Fletcher S, Amalfitano A, Petrof BJ, Kamen A, Massie B, Karpati G.

Hum Gene Ther. 2001 Sep 20;12(14):1741-55.

PMID:
11560768
48.

Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle.

Nalbantoglu J, Larochelle N, Wolf E, Karpati G, Lochmuller H, Holland PC.

J Virol. 2001 May;75(9):4276-82.

49.

Molecular therapy for glioblastoma.

Karpati G, Li H, Nalbantoglu J.

Curr Opin Mol Ther. 1999 Oct;1(5):545-52. Review.

PMID:
11249660
50.

Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes.

Wosik K, Becher B, Ezman A, Nalbantoglu J, Antel JP.

Glia. 2001 Mar 1;33(3):217-24.

PMID:
11241739

Supplemental Content

Loading ...
Support Center